Abstract

Novel human astroviruses (HAstV) were discovered 10 years ago and have been associated with fatal cases of central nervous system infections. Their role in gastroenteritis is controversial, as they have been identified in symptomatic and asymptomatic subjects. The aim of the study was to investigate novel HAstV in a gastroenteritis case-control study including a pediatric population in Spain over a one-year period. We included stool samples from patients with gastroenteritis and negative results for viruses screened by routine diagnostics, and stool samples of control subjects who sought for a routine medical consultation. All samples were screened by real-time RT-PCR assays for novel HAstV. An additional screening for rotavirus, norovirus GI, GII, sapovirus, classic HAstV and adenovirus was also performed for the control group. Overall, 23/363 stool samples from case patients (6.3%) and 8/199 stool samples from control patients (4%) were positive for ≥1 novel HAstV. MLB1 was predominant (64.5% of positives). Seasonality was observed for the case group (p = 0.015), but not the control group (p = 0.95). No difference was observed in the prevalence of novel HAstV between the case and control groups (OR 1.78, 95% CI 0.68–5.45; p = 0.30). Nevertheless, MLB genome copy numbers/ml of fecal suspension was significantly higher in the control group than in the case group (p = 0.008). In our study, we identified a lack of association between novel HAstV and gastroenteritis in the studied population, which could indicate a potential role of reservoir for children, especially given the higher viral load observed in the asymptomatic group for some of them.

Details

Title
A Spanish case-control study in <5 year-old children reveals the lack of association between MLB and VA astrovirus and diarrhea
Author
Diem-Lan, Vu 1 ; Sabrià Aurora 2 ; Aregall Nuria 3 ; Michl, Kristina 3 ; Sabrià Jaume 4 ; Rodriguez Garrido Virginia 5 ; Goterris Lidia 5   VIAFID ORCID Logo  ; Bosch, Albert 2 ; Pintó, Rosa Maria 2 ; Guix Susana 2   VIAFID ORCID Logo 

 University of Barcelona, Enteric Virus Laboratory, Department of Genetics, Microbiology and Statistics, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247); University of Barcelona, Nutrition and Food Safety Research Institute (INSA·UB), Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247); Geneva University Hospitals, Department of Infectious Diseases, Geneva, Switzerland (GRID:grid.150338.c) (ISNI:0000 0001 0721 9812) 
 University of Barcelona, Enteric Virus Laboratory, Department of Genetics, Microbiology and Statistics, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247); University of Barcelona, Nutrition and Food Safety Research Institute (INSA·UB), Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247) 
 University of Barcelona, Enteric Virus Laboratory, Department of Genetics, Microbiology and Statistics, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247) 
 Generalitat de Catalunya, Primary Health Care Center El Serral, Sant Vicenç dels Horts, Spain (GRID:grid.454735.4) (ISNI:0000000123317762) 
 Hospital Universitari Vall d’Hebron, Microbiology Department, Barcelona, Spain (GRID:grid.411083.f) (ISNI:0000 0001 0675 8654) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2350892258
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.